ELVElevance Health
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 80). Price is +19% vs its 200-day average.
Lightly shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 9.0% since the previous count, down from 2.8% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ELV is trading
Elevance Health is +28% over the past year while the S&P 500 is +16%: 12 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +19%
vs 200-day average · a clear uptrend
- RSI (14)
- 80
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 1.2%
Below its 52-week high
Details›
- Last close2026-10-23
- $439.89
- 1 monthS&P 500 −0.94%
- +10%
- 1 yearS&P 500 +16%
- +28%
- 5 yearsS&P 500 +86%
- +24%
- vs 50-day average$408.04
- +7.8%
- 52-week high
- $445.34
- 52-week low
- $277.89
- Annualised volatility
- 36%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $542K
| Year | Return |
|---|---|
| 2026 (year to date) | +27% |
| 2025 | −3.1% |
| 2024 | −21% |
| 2023 | −6.9% |
| 2022 | +12% |
| 2021 | +46% |
| 2020 | +7.7% |
| 2019 | +16% |
| 2018 | +18% |
| 2017 | +59% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.6% |
| Feb | 10 | 5 of 10 | −0.90% |
| Mar | 10 | 5 of 10 | +1.1% |
| Apr | 10 | 8 of 10 | +6.7% |
| May | 10 | 7 of 10 | +0.64% |
| Jun | 10 | 5 of 10 | −0.50% |
| Jul | 11 | 5 of 11 | −0.90% |
| Aug | 11 | 7 of 11 | +0.80% |
| Sep | 11 | 3 of 11 | −2.1% |
| Oct | 11 | 8 of 11 | +4.7% |
| Nov | 10 | 8 of 10 | +6.0% |
| Dec | 10 | 5 of 10 | +0.12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Healthcare
Ranks #18 of 436 by RyuScore